Formulations

CBD Formulations

Kanabo has developed Over the Counter (OTC) formulas, which target the growing CBD market globally. The OTC formulas contain less than 1mg THC per cartridge to meet strict regulatory requirements in multiple markets and regulatory environments. Initial OTC formulas include:

Focus

In the digital era we live in, distractions have become a huge epidemic. We check our phones every 12 minutes on average, living in constant “FOMO”. Undoubtedly, we have lost our ability to be in the present. Distractibility and hyperactivity can be calmed by increasing concentration – improving our well being, allowing us to live a better, healthier life.

  • Full Plant Hemp Extract

  • 55%

    CBD

  • 300

    Doses

  • No PG, VG, MCT & Pesticide Free

  • 250mg CBD

  • 0.5ml pod

Serenity

As our fast-paced world becomes increasingly hectic, making more and more demands on our time, angst and restlessness are becoming many people’s constant companions, interfering with job performance, study and relationships. Since we don’t always have the luxury of putting on the breaks, we need to find another way to bring some serenity to our daily lives.

  • Full Plant Hemp Extract

  • 55%

    CBD

  • 300

    Doses

  • No PG, VG, MCT & Pesticide Free

  • 250mg CBD

  • 0.5ml pod

Revive

Anyone who has ever experienced physical discomfort knows that it can cause severe pain, seriously impacting our quality of life and well-being. It can limit mobility, interfere with sleep and leave us unable to work at full capacity. By soothing the body we can revive the spirit and get back to functioning at one hundred percent.

  • Full Plant Hemp Extract

  • 55%

    CBD

  • 300

    Doses

  • No PG, VG, MCT & Pesticide Free

  • 250mg CBD

  • 0.5ml pod

Most CBD-rich products in the market today only include 1-20% CBD, while Kanabo’s OTC formulas include a full spectrum of Cannabis oil with more than 70% of cannabinoids due to patent pending compositions.

The formulas are made with a proprietary, patent-pending carrier solution that replaces the traditional electronic cigarette liquids like PG/VG and MCT oil diluents currently dominating the market, and are suspected to release toxic materials when heated to the higher temperatures required for cannabis extracts. Kanabo’s proprietary neutral diluent allows for no irritation, high potency, and consistent dosing through the lifespan of the formula pod with superior bioavailability, as indicated by Kanabo’s clinical medical trials.

COA Information

Enter batch number printed on the box to recieve a COA.

COA Information

THC Formulations

Kanabo’s R&D activities initially focused on the development of formulas of medical Cannabis oils with THC to target CNS disorders. The first formula targeted insomnia and sleep disorders. Development has included creating the finalized recipes and medical validation activities that have included literature review, anecdotal/observational studies, and a pre-clinical trial in a sleep model. The sleep formula has received U.S. PCT Patents for the unique composition of the formula.

These medical cannabis formulas will require medical prescription. Target markets for these formulas are countries with a legal medical Cannabis program.

In addition to the initial formula targeting sleep disorders, Kanabo is developing formulas to target chronic pain and anxiety, with a focus on post-traumatic stress disorder (PTSD). These formulas will be developed to target specific ailments and will be validated by performing a wide variety of studies - both pre-clinical and clinical - to assess their efficacy and safety.

Formulations mentioned below are not yet available for public purchase, as they are still in R&D, and are undergoing clinical trials.

icon-sleepCreated with Sketch.

Sleep Disorder

Targets patients who suffer from sleep disorders exacerbated by chronic pain (from various CNS disorders) and want help falling and staying asleep along with relief from pain.

Potential Targeted Conditions

Sleep disorders – insomnia, restless legs syndrome (RLS), or periodic limb movement disorder (PLMD). Structural disorders – brain or spinal cord injury/trauma, tumors, or neuropathy. Functional disorders – headache, neuralgia, or fibromyalgia.

Comparable Mainstream Medicine

Hypnotics, sedatives, melatonin supplements. Prescription sleep medications – Eszopiclone (Lunesta), nonbenzodiazepine sedative. Zolpidem (Ambien) a non-benzo hypnotic. Ramelteon (Rozerem) – a melatonin receptor agonist.

icon-painCreated with Sketch.

Chronic Pain

Targets patients who suffer from chronic pain (as a result of various CNS disorders) and want non-drowsy pain relief to stay focused throughout the day.

Potential Targeted Conditions

Structural disorders – brain or spinal cord injury/trauma, tumors, or neuropathy. Functional disorders – headache, fibromyalgia. Other disorders – arthritis, shingles, central pain syndrome.

Comparable Mainstream Medicine

Nonopioid OTCs aspirin, NSAIDs, acetaminophen Opioids – morphine, codeine, hydrocodone, and oxycodone Adjuvant analgesics – certain antidepressants and anticonvulsants.

icon-anxietyCreated with Sketch.

Anxiety Disorders

Targets patients who suffer from mood/behavior disruptions as a result of anxiety disorders.

Potential Targeted Conditions

Post Traumatic Stress Disorder (PTSD) Obsessive Compulsive Disorder (OCD) Panic Disorder

Comparable Mainstream Medicine

Benzodiazepines such as alprazolam (Xanax), chlordiazepoxide (Librium), clonazepam (Klonopin), diazepam (Valium) or lorazepam (Ativan) Selective serotonin reuptake inhibitors (SSRIs) such as escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil) or sertraline (Zoloft).